Kestra Medical Technologies, Ltd. KMTS 深 滬
已收盤 12-24 16:00:00 美东时间
27.52
-0.030
-0.11%
華盛通- 最 高27.9602
- 今 開27.65
- 成交量 9.11万股
- 最 低 26.90
- 昨 收 27.55
- 總市值 14.16亿
- 52周最高 29.9999
- 市盈率 靜 --
- 換手率 0.18%
- 52周最低 13.25
- 委 比 -85.35%
- 總股本 5144.91万
- 歷史最高 29.9999
- 量 比 0.20
- 振 幅 3.85%
- 歷史最低 13.25
- 每 手 1
- 風險率 4.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
电话会总结 ｜ Kestra Medical(KMTS)2026财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Kestra Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第二季度总营收达到2,260万美元，同比增长53%，主要由Assure系统处方量同比增长54%驱动。 **盈利能力：** 毛利率达到50.6%，较去年同期的39.6%提升11个百分点，这是公司历史上首次突破50%毛利率，实现连续第八个季度的环比改善。 **亏损情况：** GAAP净亏损为3,280万美元，较去年同期的2,060万美元扩大；调整后EBITDA亏损为1,970万美元，较去年同期的1,610万美元增加。 **现金状况：** 截至2
12-12 12:03
Kestra Medical Technologies shares are trading lower after the company reported mixed Q2 financial results.
Kestra Medical Technologies shares are trading lower after the company reported...
12-12 05:23
Kestra Medical Techs FY2026 Revenue expected $91.000M vs $88.138M Est
Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $91.000M vs $88.138M Est
12-12 05:03
Kestra Medical Techs Q2 EPS $(0.64) Misses $(0.59) Estimate, Sales $22.565M Beat $20.704M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.11 percent. The company reported quarterly sales of $22.565 million which
12-12 05:02
Earnings Scheduled For December 11, 2025
Companies Reporting Before The Bell • Hooker Furnishings (NASDAQ:HOFT) is estim...
12-11 19:11
Kestra Medical Technologies shares are trading lower after the company announced an offering of 5.5 million common shares. Also, the company reported preliminary Q2 results.
Kestra Medical Technologies shares are trading lower after the company announce...
12-02 00:23
Kestra Medical Technologies Reports Preliminary Q2 FY26 Revenue Of $22.2M To $22.6M And Gross Profit Of $11M To $11.4M
Cash and cash equivalents are expected to be approximately $175 million.
12-01 20:08
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
